TP53 and neoplasm: To determine whether Uhrf1 contributes to tumor promotion or tumor progression, we performed periodic FDG-PET/microCT scans on Tp53/Rb1 DKO and Tp53/Rb1/Uhrf1 TKO mice to determine the age at which tumors are detectable (Supplementary Fig. 8A).